Acadia Pharmaceuticals R&D head Elizabeth Thompson retires effective Oct. 23
ACAD•ACADIA Pharmaceuticals executive vice president Elizabeth H.Z. Thompson will retire as research and development head on Oct. 23, 2026, for personal reasons, and will serve as a consultant through Dec. 31.
1. Retirement and consulting role
Thompson will retire as research and development head on Oct. 23, 2026, for personal reasons. She will become a consultant that day, with limited services planned through Dec. 31, and the company is seeking her replacement.
